Valuation: RAMM Pharma Corp.

Market Cap 1.19M 849K 737K 687K 631K 80.74M 1.21M 8.1M 3.17M 40.36M 3.19M 3.12M 134M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 334K 290K 271K 249K 31.81M 476K 3.19M 1.25M 15.9M 1.26M 1.23M 52.69M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 850K
-0.88%-8.81%+44.75%+147.65% 1T
-0.20%-4.83%+48.42%+50.17% 613B
-0.38%-7.24%+23.81%+65.27% 433B
+0.48%-2.77%+40.27%+34.96% 350B
+0.08%-4.45%+31.74%+39.89% 292B
+2.09%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+2.65%-1.05%+28.82%+59.89% 204B
+1.33%-0.96%+16.17%+69.08% 163B
Average -6.87%-3.88%+26.41%+48.05% 388.94B
Weighted average by Cap. +0.27%-4.34%+33.59%+70.62%

Financials

2024 2025
Net sales 4.34M 3.09M 2.68M 2.5M 2.3M 294M 4.39M 29.46M 11.52M 147M 11.59M 11.34M 486M 3.36M 2.39M 2.07M 1.93M 1.78M 227M 3.4M 22.8M 8.91M 114M 8.97M 8.78M 376M
Net income -16.5M -11.73M -10.19M -9.5M -8.73M -1.12B -16.68M -112M -43.78M -558M -44.06M -43.09M -1.85B -8.91M -6.33M -5.5M -5.13M -4.71M -603M -9.01M -60.46M -23.64M -301M -23.79M -23.27M -998M
Net Debt -626K -445K -386K -360K -331K -42.32M -633K -4.25M -1.66M -21.15M -1.67M -1.63M -70.09M -723K -514K -447K -416K -383K -48.93M -731K -4.91M -1.92M -24.46M -1.93M -1.89M -81.04M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-